How long until Flemming gets fired?

What's your over/under on Flemming getting fired?
We all know it's very close to happening.

Our stock hit a 52 week low today while Baxter hit a 52 week high! Which is perfect since this guy 6th grade bullied his way into buying Baxter's spin off, Baxalta.

What kind of BS is Flemming gonna tell the board and investors now? Does he bully them too?

 

Amazing, isn't it? That is what you call KARMA. The Baxalta debacle is embarrassing. Thank God I took the package and ran!

 

I've admired his commitment to rare diseases and unmet needs philosophy on pipeline, but serious question here. If you build a R&D platform and pipeline that treats mostly rare diseases, how do you make a profit long term?

It is admirable to go after orphan drugs with the goal of helping these patients that have no other alternative, but these diseases are rare for a reason.....not very many people have them. What happens to a business when there aren't enough customers?

As much as the liberals want pharma to behave like a non-profit, it doesn't work that way. Pharma has every right to get ROI and profit from its intellectual property by letting the market decide how great the drug is, but how does it do that when you treat a condition that affects 1 out of every 150,000 people?

Point being that if it weren't for Vyvanse making billions, how would Shire have a future? Shire has to have a bell cow drug for the masses to have solid footing financially.

Again. Very admirable and feels good at the NSM to hear stories from these patients, but as an investor it does not appear to be sustainable. If FO is fired, it will be this strategy of being the global leader in rare diseases that does him in.

 

Shire will make billions off adderall Xr brand and generic as well as vyvanse for years to come. Shire gets government kickbacks for orphan drugs as well. Fleming is anything but admirable . He was willing to let a 6 year patient potentially die rather than agree to a compassionate use clause to give him medication for hunters . Just google it...:he cares about prestige and money that's it. He goes into companies, preps them to be sold or merge then leaves with a big paycheck then takes his band of idiots KK and PS with him. The only reason he's still here is because the Abbvie merger failed and he didn't get his millions and shire couldn't be sold any longer Bc the price was too high. He doesn't give a shit about anyone but himself and his pockets

 

What are you talking about. There's nothing noble here. Dry Eye and ADHD are anything but "rare." The only commitment has been to telling whatever story FO thought Wall Street wanted to hear, buy whatever he could, push sales to make numbers, hire his buddies, and take in a big salary. The 4 year low in the stock, the crispy morale, and lack of a real pipeline shows he's failed.

 

And we all get to chase a dangling carrot of unattainable goals so he can hit his 20/20 garbage . It doesn't work, reps don't work for free. They either stay home or get a better job. I've never seen lower motivation to work because hitting 100% is a pipe dream now

 

The ship is sinking fast! FO is a sociopath that brings along his band of lying unqualified losers. He has no IDEA on how to sell Rare Disease products. All he and his band of gypsies know is BIG PHARMA 101. All of his lies and horrible decisions are coming back to haunt him now........it's only a matter of time and he'll take his millions and exit to destroy another great company.

 

There is not one person in senior leadership that has any experience in rare disease. Simply buying rare disease companies does not mean you have a clue what you are doing.

 

But wait, it's not as he describes his role or the business in this brand new McKinsey article ??!! Apparently if you pay lots of money to a consulting firm, they'll offer you as bonus, an interview.

http://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/leadership-and-strategic-innovation-in-pharma?cid=other-eml-alt-mip-mck-oth-1707&hlkid=4c0b7c5827794071b5a9a4c8a65c5e79&hctky=9227944&hdpid=84c8141b-163b-4ac7-8ffd-ef88cd803476

 

Quid pro quo if it ever existed!

 

Perhaps "Mr. Change" will be changing employers soon after Q2 earnings are public!

This part of that interview is gonna do him in:
"We’ve evaluated every deal Shire has done through a deep understanding of the products and the patients we serve. Subsequently, I’ve worked with my team to understand the financials,"

 

Idiots teaching idiots results in an Idiot!

 

"Lack of growth?"
"Ripe for a change?"
"Have to move fast to stay independant?"
This guy is the corporate version of OJ Simpson. Completely out of touch with reality and a patholigical liar. He exposed himself when he negotiated away the security of his people after he ran to every big pharma company trying to sell us. Then AbbVie walked away and he had egg on his face.

If anyone trusts this line of shit I have a bridge to sell you.

 

TRUTH

 

The value of consultants is easily demonstrated by the poor fact-checking of FO's statements. Apparently McKinsey (and FO) "forgot" several billion-dollar deals done before FO arrived, notably TKT, the deal that made us a rare disease company ( not counting the billions Vyanse provides). Reading this, it's easy to see how McKinsey "assistance" worked so well for Shire, Valeant, Endo etc.

 

FO could be gone as early as right after earnings are reported in August, or maybe they will give him til year end to turn things around. Of course they will do it in a way that allows him to save face. Maybe they will say he is leaving so he can relocate to Africa to do humanitarian work with children.

 

More likely the Board is worrying about saving their own reputations given the dismal performance of the stock and exodus of talent.

 

They need to explore a new revolutionary idea....contract upper management

 

Hahahaha.

 

Love it!
Let's replace Flemming, Perry and the gang with some contractors, perhaps early retirees from another pharma.